div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: fileMIRCERA ONCE-MONTHLY methoxy beta Continuous activity Targeted stability For the treatment of CKD-related anaemia benefit is simplification-r src=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: fileMIRCERA ONCE-MONTHLY methoxy beta Continuous activity Targeted stability For the treatment of CKD-related anaemia benefit is simplification-r src=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: fileMIRCERA ONCE-MONTHLY methoxy beta Continuous activity Targeted stability For the treatment of CKD-related anaemia benefit is simplification-r src=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: fileMIRCERA ONCE-MONTHLY methoxy beta Continuous activity Targeted stability For the treatment of CKD-related anaemia benefit is simplification-r src=https:reader039fdocumentsusreader039viewer20220314105c6450ea09d3f29e1d8c8b39html5thumbnails4jpg width=142...